Company Analysis

Vaxcyte, Inc. (PCVX)

Nasdaq: PCVX · Biological Products, (No Diagnostic Substances) · San Carlos, CA · filing with the SEC since 2015
Grade5.0
◀ Past 5.3● Present 6.2▶ Future 3.7
6 est.

Income statement, as filed

In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.
Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period endingDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018
Report filedFeb 24, 2026Feb 25, 2025Feb 27, 2024Feb 27, 2023Feb 28, 2022Mar 29, 2021··
Research and development794,306476,644332,341169,45178,41173,56445,60730,145
General and administrative129,36992,90260,70039,81025,25916,0178,5465,388
Total operating expenses923,675569,546468,041232,256103,67089,58154,15335,533
Operating income-923,675-569,546-468,041-232,256-103,670-89,581-54,153-35,533
Interest expense·002774075
Interest and investment income119,718109,99462,9078,356344244632903
Other income (expense), net37,329-4,375r2,868r8,7713,5933643,8796,048
Total non-operating income (expense)157,047105,61965,775·····
Income tax expense000·····
Net income including non-controlling interests-766,628-463,927-402,266-223,485-100,077-89,217-50,274-29,485
Net income-766,628-463,927-402,266-223,485-100,077-89,217-50,274-29,485
Net income to common shareholders-766,628-463,927-402,266-223,485-100,077-89,217-50,274-29,485
Earnings per share, basic-5.63-3.80-4.14-3.44-1.93-3.02··
Earnings per share, diluted-5.63-3.80-4.14-3.44-1.93-3.02··
Earnings per share, basic and diluted····-1.93-3.02-13.25-8.12
Weighted average shares, basic136,089,506121,997,34897,157,69064,877,98851,922,10829,545,810··
Weighted average shares, diluted136,089,506121,997,34897,157,69064,877,98851,922,10829,545,810··
Weighted average shares, basic and diluted····51,922,10829,545,8103,795,0903,629,896
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense
General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense
Total operating expenses the running costs togetherus-gaap:OperatingExpenses
Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss
Interest expense what its borrowing costus-gaap:InterestExpenseNonoperating
us-gaap:InterestExpense
Interest and investment income what its cash and investments earnedus-gaap:InvestmentIncomeInterest
Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense
Total non-operating income (expense) everything outside the business, togetherus-gaap:NonoperatingIncomeExpense
Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit
Net income including non-controlling interests the whole group's profit, minority holders' share includedus-gaap:ProfitLoss
Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss
Net income to common shareholders what is left for common shareholdersus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic
Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted
Earnings per share, basic and diluted net income per share, where both counts are the sameus-gaap:EarningsPerShareBasicAndDiluted
Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic
Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Weighted average shares, basic and diluted the average count, where both counts are the sameus-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
SI Assistanton PCVX · research, not advice